Merck’s HIV treatment meets main goal of two late-stage studies

(Reuters) – Merck said on Thursday its experimental drug combination to treat some adults with HIV-1 infection met the main goal of two late-stage studies.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)